scispace - formally typeset
Journal ArticleDOI

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Palle Petersen, +4 more
- 28 Jan 1989 - 
- Vol. 333, Iss: 8631, pp 175-179
Reads0
Chats0
TLDR
The incidence of thromboembolic complications and vascular mortality were significantly lower in the warfarin group than in the aspirin and placebo groups, which did not differ significantly.
About
This article is published in The Lancet.The article was published on 1989-01-28. It has received 1636 citations till now. The article focuses on the topics: Warfarin & Stroke.

read more

Citations
More filters
Journal ArticleDOI

Heart–brain relationship: atrial fibrillation and stroke

TL;DR: In this article, randomized trials have shown that anticoagulation and aspirin are safe in patients with NVAF, leading to 70% and 22% risk reduction of strokes, respectively.
Journal ArticleDOI

Neurologia y cardiologia: puntos de contacto

TL;DR: Cardiologists and neurologists share responsibility for caring for patients with or at risk for cardiogenic strokes, and for screening and managing the heart disease associated with neuromuscular disorders.
Journal ArticleDOI

Propafenone and sotalol in the prevention of paroysmal atrial fibrillation: long-term safety and efficacy study

TL;DR: The efficacy and tolerability of propafenone and sotalol in the prevention of paroysmal atrial fibrillation (AF) were assessed in a doubleblind placebo-controlled study over 1 year.
Journal ArticleDOI

Does warfarin enhance platelet activity

C Mieszczak, +1 more
- 15 Nov 1996 - 
TL;DR: The aim of the present study was to test if warfarin affects platelet aggregation induced by ADP, adrenaline and collagen, and to determine if the enhancement of platelet activation is indeed caused by Warfarin.
Journal ArticleDOI

Should all patients with atrial fibrillation be screened with echocardiography

TL;DR: Though performing echocardiography on all patients with atrial fibrillation gave the best quality-adjusted life expectancy, the differences among the five strategies studied were small and sensitivity analysis revealed that the decision was sensitive to many of the variables used in the analysis.
References
More filters
Journal ArticleDOI

A multiple testing procedure for clinical trials.

TL;DR: The overall size of the procedure is shown to be controlled with virtually the same accuracy as the single sample chi-square test based on N(m1 + m2) observations and the power is found to bevirtually the same.
Journal ArticleDOI

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study

TL;DR: Controlled trials of anticoagulants or antiarrhythmic agents in persons with chronic AF may demonstrate if strokes can be prevented in this highly susceptible group.
Journal ArticleDOI

Explanatory and pragmatic attitudes in therapeutical trials

TL;DR: Most therapeutic trials are inadequately formulated from the earliest stages of their conception, and it often occurs that one type of approach is ethically less defensible than the other, or may even be ruled out altogether on ethical grounds.
Journal ArticleDOI

Randomised trial of prophylactic daily aspirin in British male doctors

TL;DR: A six year randomised trial was conducted among 5139 apparently healthy male doctors to see whether 500 mg aspirin daily would reduce the incidence of and mortality from stroke, myocardial infarction, or other vascular conditions.
Journal ArticleDOI

The natural history of lone atrial fibrillation. A population-based study over three decades.

TL;DR: It is concluded that lone atrial fibrillation in patients under the age of 60 at diagnosis is associated with a very low risk of stroke, and routine anticoagulation may not be warranted.
Related Papers (5)